On November 1, 2017, ODPHP held a free public listening session titled Partnering to Prevent Hypoglycemia in Washington, DC. Participants included federal partners, public and private health professionals, organizations, and consumer representatives.
Keynote speakers included:
- Don Wright, MD, MPH, Deputy Assistant Secretary for Health and Director of ODPHP, U.S. Department of Health and Human Services
- LaShawn McIver, MD, MPH, Senior Vice President of Government Affairs and Advocacy, American Diabetes Association
The listening session focused on hypoglycemia as an important public health issue and federal efforts to reduce hypoglycemic adverse drug events (ADEs).
We’re pleased to invite you to view the meeting summary and slides from the listening session.
The materials include presentations from:
- Cathy Abramson, Patient, Saulte Ste. Marie Tribe, Indian Health Service
- Brian Burke, MD, Chief, Diabetes Service, Heart Failure Clinic, Dayton, VA; Co-Chair, Choosing Wisely: Hypoglycemia Safety Initiative, Veterans Health Administration
- Kelly L. Close, Founder and Editor-in-Chief, diaTribe.org; President, Close Concerns, Inc.
- Alaina Fournier, PhD, Health Communications Specialist, Agency for Healthcare Research and Quality
- Wendy Frisby, Patient, Novo Nordisk and Diabetes Advocacy Alliance
- Sandra C. Hedin, PharmD, BCACP, Clinical Pharmacy Specialist, Co-Chair Choosing Wisely: Hypoglycemia Safety Initiative, Veterans Health Administration
- Beverley Johnson, President and CEO, Institute for Patient- and Family-Centered Care
- Christine Lee, PharmD, PhD, Professional Affairs and Stakeholder Engagement, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
- Paul Madden, MEd, Director, Diabetes and Behavioral Health, American Diabetes Association
- Leonard Pogach, MD, MBA, VACO National Director, Medical Services and Diabetes and Endocrinology, Office of Specialty Care and Office of Patient Care Services, Veterans Health Administration
- Barbarajean Shaneman-Robinson, RN, MS, Senior Program Specialist, School of Pharmacy, University of Maryland
- Lorraine Stiehl, Diabetes Patient Advocate for 30 Years
- Chris Stiehl, Patient with Type 1 Diabetes for 57 Years
- John Whyte, MD, MPH, Director, Professional Affairs and Stakeholder Engagement, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
We hope you enjoy these new resources!
